Publication Database

PKCα deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 and increased thromboxane receptor expression (2015)

Art

Zeitschriftenartikel / wissenschaftlicher Beitrag

Autoren

Tabeling, Christoph

Noe, Elena

Naujoks, Jan

Doehn, Jan-Moritz

Hippenstiel, Stefan

Opitz, Bastian

Suttorp, Norbert

Klopfleisch, Robert (WE 12)

Witzenrath, Martin

Quelle

Journal of vascular research : official journal of the European Society of Microcirculation

Bandzählung: 52

Heftzählung: 4

Seiten: 279 – 288

ISSN: 1018-1172

Sprache

Englisch

Verweise

URL (Volltext): https://www.karger.com/Article/FullText/443402

DOI: 10.1159/000443402

Pubmed: 26890419

Kontakt

Institut für Tierpathologie

Robert-von-Ostertag-Str. 15
14163 Berlin
+49 30 838 62450
pathologie@vetmed.fu-berlin.de

Abstract / Zusammenfassung

Pulmonary vascular hyperresponsiveness is a main characteristic of pulmonary arterial hypertension (PAH). In PAH patients, elevated levels of the vasoconstrictors thromboxane A2 (TXA2), endothelin (ET)-1 and serotonin further contribute to pulmonary hypertension. Protein kinase C (PKC) isozyme alpha (PKCα) is a known modulator of smooth muscle cell contraction. However, the effects of PKCα deficiency on pulmonary vasoconstriction have not yet been investigated. Thus, the role of PKCα in pulmonary vascular responsiveness to the TXA2 analog U46619, ET-1, serotonin and acute hypoxia was investigated in isolated lungs of PKCα-/- mice and corresponding wild-type mice, with or without prior administration of the PKC inhibitor bisindolylmaleimide I or Gö6976. mRNA was quantified from microdissected intrapulmonary arteries. We found that broad-spectrum PKC inhibition reduced pulmonary vascular responsiveness to ET-1 and acute hypoxia and, by trend, to U46619. Analogously, selective inhibition of conventional PKC isozymes or PKCα deficiency reduced ET-1-evoked pulmonary vasoconstriction. The pulmonary vasopressor response to serotonin was unaffected by either broad PKC inhibition or PKCα deficiency. Surprisingly, PKCα-/- mice showed pulmonary vascular hyperresponsiveness to U46619 and increased TXA2 receptor (TP receptor) expression in the intrapulmonary arteries. To conclude, PKCα regulates ET-1-induced pulmonary vasoconstriction. However, PKCα deficiency leads to pulmonary vascular hyperresponsiveness to TXA2, possibly via increased pulmonary arterial TP receptor expression.